Vivos Therapeutics (VVOS) EPS (Weighted Average and Diluted) (2022 - 2026)
Vivos Therapeutics (VVOS) reported EPS (Weighted Average and Diluted) of -$0.52 for Q1 2026, down 15.56% year-over-year from -$0.62 in Q1 2025, and up 10.34% on a QoQ basis from -$0.58 in Q4 2025.
Vivos Therapeutics (VVOS) has 5 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.52 in Q1 2026.
- Quarterly EPS (Weighted Average and Diluted) fell 15.56% year-over-year to -$0.52 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.14 (down 23.7% YoY) and the FY2025 annual result came in at -$2.07, up 6.76% from the prior year.
- EPS (Weighted Average and Diluted) advanced to -$0.52 in Q1 2026 per VVOS's latest filing, from -$0.58 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at -$0.28 in Q4 2024 and bottomed at -$6.4 in Q3 2022.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.59 (2025), against an average of -$1.77.
- The widest annual swing landed in 2023, when EPS (Weighted Average and Diluted) tumbled 1300.0%; it then surged 90.82% in 2024.
- Tracing VVOS's EPS (Weighted Average and Diluted) over 5 years: stood at -$5.0 in 2022, then soared by 39.0% to -$3.05 in 2023, then surged by 90.82% to -$0.28 in 2024, then slumped by 107.14% to -$0.58 in 2025, then increased by 10.34% to -$0.52 in 2026.
- Per Business Quant, the three latest VVOS EPS (Weighted Average and Diluted) figures stand at -$0.52 (Q1 2026), -$0.58 (Q4 2025), and -$0.49 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn | -0.52 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.52 |
| Dec 31, 2025 | -0.58 |
| Sep 30, 2025 | -0.49 |
| Jun 30, 2025 | -0.55 |
| Mar 31, 2025 | -0.45 |
| Dec 31, 2024 | -0.28 |
| Sep 30, 2024 | -0.40 |
| Jun 30, 2024 | -0.60 |
| Mar 31, 2024 | -1.63 |
| Dec 31, 2023 | -3.05 |
| Sep 30, 2023 | -1.75 |
| Jun 30, 2023 | -4.62 |
| Mar 31, 2023 | -1.72 |
| Dec 31, 2022 | -5.00 |
| Sep 30, 2022 | -6.40 |
| Jun 30, 2022 | -0.33 |